Farallon Capital Management 13F, Q3 2025
Farallon Capital · quarter ending 30 September 2025 · filed 17 February 2026 · SEC CIK 909661
Common stock only: shares the fund reported owning at the quarter end, valued as filed. The filing also lists 5 put and call lines, reported at the value of the underlying shares; they are not ownership and are not in these totals.
Largest positions, Q3 2025
The 25 largest of 139 positions. Weights are against the whole filed book. Changes are in shares held, against the Q2 2025 filing.
| Company | Ticker | Value | % of book | vs Q2 2025 |
|---|---|---|---|---|
| MICROSOFT CORP | MSFT | $990.91M | 5.6% | new |
| AON PLC | $812.30M | 4.6% | new | |
| EXELIXIS INC | EXEL | $805.41M | 4.5% | new |
| AMAZON COM INC | AMZN | $769.75M | 4.3% | new |
| NATERA INC | NTRA | $684.68M | 3.9% | new |
| REVOLUTION MEDICINES INC | RVMD | $683.02M | 3.9% | new |
| UNITEDHEALTH GROUP INC | UNH | $651.41M | 3.7% | new |
| THERMO FISHER SCIENTIFIC INC | TMO | $610.27M | 3.5% | new |
| HIMS & HERS HEALTH INC | HIMS | $609.56M | 3.4% | new |
| DISNEY WALT CO | DIS | $595.28M | 3.4% | new |
| SALESFORCE INC | CRM | $583.57M | 3.3% | new |
| AUTODESK INC | ADSK | $528.24M | 3.0% | new |
| BOSTON SCIENTIFIC CORP | BSX | $463.41M | 2.6% | new |
| ISHARES BITCOIN TRUST ETF | IBIT | $454.53M | 2.6% | new |
| WABTEC | WAB | $442.06M | 2.5% | new |
| BRIDGEBIO PHARMA INC | BBIO | $425.49M | 2.4% | new |
| PROTAGONIST THERAPEUTICS INC | PTGX | $411.60M | 2.3% | new |
| TRANSUNION | TRU | $396.45M | 2.2% | new |
| ARAMARK | ARMK | $345.45M | 1.9% | new |
| INTUIT | INTU | $333.32M | 1.9% | new |
| KELLANOVA | $323.47M | 1.8% | +124% shares | |
| NASDAQ INC | NDAQ | $320.46M | 1.8% | new |
| ANALOG DEVICES INC | ADI | $319.29M | 1.8% | new |
| SCHWAB CHARLES CORP | SCHW | $310.44M | 1.8% | new |
| NEW YORK TIMES CO | NYT | $286.18M | 1.6% | new |
What changed since Q2 2025
Against the Q2 2025 filing, Farallon Capital Management opened 138 new positions, added to 1, trimmed 0, left 0 unchanged and exited 0. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0000908834-26-000086, filed by FARALLON CAPITAL MANAGEMENT, L.L.C.. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.